Atlas Trials

Autologous Cell Suspension Grafting Using ReCell in Vitiligo and Piebaldism Patients

Clinical trial NCT01640678 · UNKNOWN

Trial details

NCT number
NCT01640678
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
PiebaldismSegmental Vitiligo
Start date
2012-06-01
Primary completion
2013-09-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.